-5%
Levodopa: As a precursor to dopamine, levodopa crosses the blood-brain barrier and is converted into dopamine in the brain. This increase in dopamine levels is believed to alleviate Parkinson’s disease symptoms.
Carbidopa: When administered orally, levodopa undergoes rapid peripheral conversion to dopamine, reducing its availability for the central nervous system. Carbidopa prevents this premature breakdown, thereby increasing the amount of levodopa that reaches the brain.
Supadopa TR is prescribed for managing Parkinson’s disease, post-encephalitic parkinsonism, and cases of parkinsonism induced by exposure to carbon monoxide or manganese toxicity.
- Follow your doctor’s prescribed dosage and schedule strictly.
- Avoid consuming high-protein foods (e.g., meat, dairy, eggs) close to medication intake, as it may reduce absorption.
- Rise slowly from sitting or lying positions to prevent dizziness.
- Do not stop taking the medication suddenly without consulting your doctor.
- If unusual behavior changes or hallucinations occur, report them immediately